亚托邦性皮肤炎:诊断,分子病原和治疗方法
Ruimin Bai1, Yan Zheng1, Xiaofeng Dai2
1Department of Dermatology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an Jiaotong University, No.277 Yanta West Road, Xi'an, Shaanxi, 710061, China.
Molecular biomedicine
|October 5, 2025
概括
无氧性皮肤炎 (AD) 涉及复杂的免疫反应和氧化还原失衡. 一种新的伤口愈合模型解释了AD的进展,并引入冷大气等离子体 (CAP) 作为潜在的氧化还原调节疗法.
科学领域:
- 免疫皮肤学 免疫皮肤学
- 分子生物学分子生物学
- 伤口愈合研究研究研究
背景情况:
- 亚托匹性皮肤炎 (AD) 是一种慢性炎症性皮肤病,没有治愈的方法.
- 阿尔茨海默病的发病包括遗传,环境和免疫因素,有不同的Th2 (急性) 和Th1 (慢性) 反应.
- 氧化还原失衡在阿尔茨海默病的进展中起着至关重要的作用.
研究的目的:
- 为了提供对亚托皮性皮肤炎的全面概述.
- 为了解AD分子动态引入一个伤口愈合模型.
- 探索新的治疗策略,包括冷大气等离子体 (CAP).
主要方法:
- 关于AD病原和治疗的当前文献的综述.
- 介绍了AD的概念性伤口愈合模型.
- 在AD急性和慢性阶段对氧化还原失衡的分析.
主要成果:
- 伤口愈合模型阐明了AD的急性 (氧化应激) 和慢性 (不足的氧化还原信号) 阶段.
- 冷大气等离子体 (CAP) 被介绍为AD的氧化还原调节工具.
- 通过调节氧化应激,CAP显示了扭转慢性AD病理的潜力.
结论:
- 抗炎症管理需要了解其复杂的病原和氧化还原动力学.
- 伤口愈合模型为整合新型疗法提供了一个框架,例如CAP.
- CAP代表了一种有前途的创新治疗方式,用于治疗亚托皮炎.
相关概念视频
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Skin Diseases and Disorders
5.2K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.2K


